These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36861577)

  • 1. Institutional Patterns of Care of Diffuse Intrinsic Pontine Glioma.
    Krishnatry R; Mani S; Manjali JJ; Rane PP; Chatterjee A; Goda JS; Janu A; Sahu A; Gupta T; Jalali R
    Neurol India; 2023; 71(1):72-78. PubMed ID: 36861577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.
    Krishnatry R; Manjali JJ; Chinnaswamy G; Chatterjee A; Goda JS; Janu A; Sahu A; Jalali R; Gupta T
    Jpn J Clin Oncol; 2021 Apr; 51(5):762-768. PubMed ID: 33521824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
    Mankuzhy NP; Tringale KR; Dunkel IJ; Farouk Sait S; Souweidane MM; Khakoo Y; Karajannis MA; Wolden S
    Pediatr Blood Cancer; 2024 May; 71(5):e30929. PubMed ID: 38430472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
    Zamora PL; Miller SR; Kovoor JJ
    Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
    Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
    J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomic Features Based on MRI Predict Progression-Free Survival in Pediatric Diffuse Midline Glioma/Diffuse Intrinsic Pontine Glioma.
    Wagner MW; Namdar K; Napoleone M; Hainc N; Amirabadi A; Fonseca A; Laughlin S; Shroff MM; Bouffet E; Hawkins C; Khalvati F; Bartels U; Ertl-Wagner BB
    Can Assoc Radiol J; 2023 Feb; 74(1):119-126. PubMed ID: 35768942
    [No Abstract]   [Full Text] [Related]  

  • 10. Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study.
    Kim HJ; Lee JH; Kim Y; Lim DH; Park SH; Ahn SD; Kim IA; Im JH; Chung JW; Kim JY; Kim IH; Yoon HI; Suh CO
    Cancer Res Treat; 2023 Jan; 55(1):41-49. PubMed ID: 35255651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
    Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
    Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.
    Wang Y; Pan C; Xie M; Zuo P; Li X; Gu G; Li T; Jiang Z; Wu Z; Zhang J; Zhang L
    J Neurosurg; 2022 Dec; 137(6):1628-1638. PubMed ID: 35395636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma : A case study.
    Bergengruen PM; Hernaíz Driever P; Budach V; Zips D; Grün A
    Strahlenther Onkol; 2023 Aug; 199(8):773-777. PubMed ID: 36862153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project.
    Chavaz L; Janssens GO; Bolle S; Mandeville H; Ramos-Albiac M; Van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Seidel C; Kortmann RD; Hargrave D; Gandola L; Pecori E; van Vuurden DG; Biassoni V; Massimino M; Kramm CM; von Bueren AO
    Front Oncol; 2022; 12():926196. PubMed ID: 35814457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
    Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
    Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
    Shi S; Lu S; Jing X; Liao J; Li Q
    World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.
    Szychot E; Walker D; Collins P; Hyare H; Shankar A; Bienemann A; Hollingworth M; Gill S
    Int J Clin Oncol; 2021 Apr; 26(4):647-658. PubMed ID: 33575829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
    J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.